glp-1 dose Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are When to Titrate Up Your

The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications

Accelerated Recovery Times Elevated GH from Ipamorelin shortens the time between intensive training sessions by accelerating the repair of muscle fibers and connective tissue

If you want help narrowing your next step, Take the Quiz for a more personalised starting point

Patients frequently report feeling revitalized and more energetic shortly after treatment, an experience that highlights its compelling potential as a therapeutic option

Long-acting agents (e.g., dulaglutide, semaglutide, and liraglutide) provide better control of fasting glucose and HbA1c levels